Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Teriparatide and Raloxifene in Postmenopausal Osteoporosis
NCT00046137Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raloxifene in osteoporosis, sponsored by Eli Lilly and Company. Status: completed.
02
Drugs
raloxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00046137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046137.